FAIL (the browser should render some flash content, not this).

Press Room
/08-30-2010/
VenxMedical, LLC, Announces First Round of Series A Financing from TriStar Technology Fund, LLC more

 

About Nanoplebectomy
Small diameter veins, such as reticular veins and spider veins are generally too small to be treated using current amulatory phlebectomy techniques. This led the founders of VenX to seek ways to improve ambulatory phlebectomy techniques for smaller diameter reticular and spider veins.


 

Revolutionary Spider Vein Device
The Nanophlebectomy is a handheld, disposable device developed to injure spider and reticular veins in a transdermal fashion by piercing the vein and disrupting the layers of the vein such that the vein coagulates and then undergoes a wound healing response that results in its elimination. The goal is to disrupt the layers of the vein in the most complete fashion with a minimum of residual inflammation. Furthermore, this is done is a transdermal fashion, rather than endovenous, as is commonly done for larger veins with endovenous ablation.

The key differentiating factor between the Nanophlebectomy device and sclerotherapy is that there is no injection of a sclerotherapy agent, and thus the downside of sclerotherapy is averted. In particular, like standard phlebectomy, it is expected, that there will be no staining, matting and potential for ulceration as one sees with sclerotherapy. Furthermore, there is not potential for deep vein and systemic complications that are of concern with standard liquid and foam sclerotherapy.

   
VenXmedical.com © 2010
an MDI Partners Company
Welcome   |   Spider Veins  |   M.A.T Device   |   VenX Medical   |   Contact Us